Scientist, Non-Viral Gene Editing Platforms
Bristol Myers Squibb - Seattle 400 Dexter - WA - US
Posted Oct 19, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $123K-$149K From the posting source checked Nov 17, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Mid From the posting source checked Nov 17, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 17, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Scientist, Non-Viral Gene Editing Platforms Seattle 400 Dexter - WA - US At Bristol Myers Squibb, our employees often ask, “Who are you working for?”-a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it. The Cell Therapy Thematic Research Center is one of BMS's differentiated research platforms delivering innovative therapies to patients. Our mission is to drive leadership in the use of cellular therapies to harness the power of the immune system in treating hematologic malignancies, solid cancers, and autoimmune disease. More specifically, our discovery and translational scientists are focused on developing next-generation, engineered cell-based therapies. The team is committed to discovering and developing transformative therapies that harness the power of the immune system to improve patient outcomes. Position Responsibilities In this role as a Scientist, Non-Viral Gene Editing Platforms, the ideal candidate: Spends a majority of the time working in the lab independently executing experiments and recording detailed ELN entries Works diligently within the team to optimize base ex vivo editing platform and implement new technologies for continuous improvement and next-gen in vivo platform development (e.g., lipid nanoparticles) Routinely generates CAR-T cells including non-viral gene editing, expansion, and cryopreservation of engineered cells
Read the full description at bristolmyerssquibb.wd5.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Senior Scientist, Cell Therapy Research, Molecular Immunobiology and Discovery Team (In vivo CAR-T)
Bristol Myers Squibb - Seattle 400 Dexter - WA - US
Scientist, Viral Vector Process Development
Asimov - Boston, MA
Scientist 3, Translational Oncology
Genentech, Inc. - South San Francisco, California, United States of America
Staff Scientist
Danaher Corporation - Boulder, Colorado, United States of America